BackThe Precision Peptide Company Overview

The Precision Peptide Company Goodwill

Track The Precision Peptide Company's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00
↓ 100.00% YoYΔ $-863155.00 vs prior year quarter

Peer trimmed avg / median

Loading

The Precision Peptide Company Goodwill History

Loading

The Precision Peptide Company vs. peers: Goodwill Comparison

Loading

The Precision Peptide Company Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

The Precision Peptide Company (PNGAF) FAQ

The latest goodwill for PNGAF is $0 as of July 2026. That compares with $860K in the prior-year period — down 100.0% year over year. Investors often review this figure alongside The Precision Peptide Company's historical trend and sector peers before judging valuation or financial health.

Over the past year, PNGAF's goodwill moved from $860K to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in The Precision Peptide Company's operating scale or balance-sheet position.

A goodwill figure of $0 for PNGAF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PNGAF's goodwill ($0), review year-over-year change from $860K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.